DiaMedica Therapeutics Inc (NASDAQ:DMAC)

3.74
Delayed Data
As of Dec 13
 +0.36 / +10.65%
Today’s Change
1.70
Today|||52-Week Range
5.93
+28.52%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for DiaMedica Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +140.64% increase from the last price of 3.74.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in DiaMedica Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$0.00
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -43.33%
 
 
 
 
 
 
Growthannually -30.63%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually -100.00%
 
 
 
 
 
Key to the earnings and sales forecast charts.